Coumarin derivative
AssigneeInstitute of Medicinal Molecular Design, Inc.
InventorsSusumu Muto, Masayuki Komukai, Akiko Itai
Life of this patent
Estimating the term…
Loading patent…
AssigneeInstitute of Medicinal Molecular Design, Inc.
InventorsSusumu Muto, Masayuki Komukai, Akiko Itai
Estimating the term…
A medicament for enhancing an effect of a cancer therapy based on a mode of action of DNA injury, which comprises as an active ingredient a compound represented by the following general formula (I): wherein X represents a single bond or a C1 to C6 alkylene group which may be substituted; A represents a C1 to C6 alkyl group which may be substituted, a C6 to C10 aryl group which may be substituted, or a 4 to 10-membered monocyclic or bicyclic and unsaturated, partly saturated, or completely saturated heterocyclic group which may be substituted, wherein said heterocyclic group comprises as ring-constituting atoms 1 to 4 hetero atoms selected from the group consisting of nitrogen atom, oxygen atom, and sulfur atom.
A compound represented by the general formula (II) or a salt thereof:
Dependencies are inferred from the claim text.